Lattice Medical is a biomedical start-up that was launched in October 2017
Patented 3D technology developed with CHU Lille-France that allows adipose tissue to naturally regenerate
APPLICATIONS
THE MAT(T)ISSE BIOPROTHESIS:
A BIO-RESORBABLE TEC
(TISSUE ENGINEERING CHAMBER)
RESORBABLE CHAMBER
Designed and made
with 3D printed biomaterials
Adapted to the individual morphology of patients
Fully degrades
in a year
PATIENT AUTOLOGOUS ADIPOSE TISSUE GRAFTING
Vascular adipose flap tissue inlaid
over the Tissue Engineering Chamber (TEC)
Guided tissue
reconstruction
Regenerates patients’
adispose cells
The desired size is reached after just one surgery: breasts are entirely reconstructed by the patient’s tissues, and no foreign bodies are introduced.
SUBCUTANEOUS TISSUE
AND FACIAL RECONSTRUCTION
Lattice Medical also provides solutions for improving tissue engineering and regenerative medicine using 3D-printed bio-resorbable scaffolds.
Following surgery, serious burns, chronic wounds, and accidents, traumatized soft tissue needs to be repaired.
In collaboration with CHU Lille, Lattice Medical provides product design, R&D services, and various solutions for soft tissue engineering and regeneration. Alongside textile manufacturing partners, we develop textile matrixes (including Calais lace ones) that are obtained through the Leavers method.
Lattice Medical offers sub-licensing R&D contracts to manufacturers and provides pre-clinical proof-of-concept studies.
SOFT TISSUE RECONSTRUCTION PLATFORM
A new era in medical application development
Thanks to its integrated platform, Lattice Medical is able to offer innovative solutions and the opportunity for biomedical projects to explore new technological landscapes. Lattice Medical is helping manufacturers in the medical procedure industry with their transition towards 3D technology.
Lattice Medical is developing the first ISO 13485 production in clean room with 3D printing for designing personalized implantable resorbable medical devices.
This unique platform is endowed with new 3D printing and extrusion technology that is able to produce prototypes, pre-series and industrial series for R&D trials, pre-clinical and clinical studies at extremely low particular pollution levels.
More information available on https://lattice-services.com/
SERVICES
SITEDRUG
Interreg 2 Seas project “Site-Specific Drug Delivery” (Site Drug)
E-SHOP
FILAMENTS FOR 3D PRINTING
Want to test specific medical grade polymers for R&D purpose in 3D printing medical area such as tissue engineering, custom medical devices or 3D printed prototypes. Try our filaments for 3D printing.
NEW : See our new website dedicated to 3D Printing Filaments and 3D printing for medical devices – https://lattice-services.com/
TEAM
Justine Bax
Quality and Regulatory Affairs
Kévin ROUX
Process Engineer
Shengheng Cao
Biomedical Engineer
Dr. Pierre-Marie Danzé
Biochemist and Scientific Advisor
Jaime Destouesse-Villa
Mechanical Engineer
Marion Gradwohl
Material Engineer
Pr. Pierre Guerreschi
Plastic and Reconstructive Surgeon and Scientific Advisor
Pr. Philippe Marchetti
Biologist and Scientific Advisor
Damien Cleret
Pre-clinical Studies
Julien Payen
CEO, Co-founder
Zelzima Amelia Jordao
Biology Engineer
Jérôme Segers
Quality Engineer
Siham Bouyouaaran
Human Ressources
Chloé Gigon
Industrialisation Engineer
Mégann Le Rest
Biomaterials Engineer
Lou Pasquier
Methods Engineer
Guillaume Bruniaux
Mission Director at SIPAREX for Nord France Amorçage
Hélène Cannard
Member of the executive management at FINOVAM GESTION
François Martin
Associate Partner with Schnopp & Partner
Nicolas Blanchemain
Assistant Professor at Lille University, Biomaterials, Medical Devices and Drug Delivery
Pr. Mathias Brieu
Professor at Cal State Los Angeles, Mechanical Engineering
Pr. Xavier Garric
Professor at Montpelier University, Artificial Biopolymers
Dr. Nicolas Leymarie
Plastic and Reconstructive Surgeon, Gustave Roussy
Isabelle Martinache
Tissue referring doctor, French Biomedicine Agency
Pr. Michel Toungouz
Center for Tissue and Cell Therapy, Head of Clinic, Saint Luc and Bruxelles UniversityPRESS REPORT
PRESS RELEASE - LATTICE MEDICAL announces the closing of a €8 million Series A financing round
Lille, October 1, 2022 – LATTICE MEDICAL, announces the closing of a second round of financing of 8 million euros. This round was led by the historical funds Finovam Gestion, Nord France Amorçage and WiSEED alongside the Captech Santé fund. The European Commission, via its EIC Fund, and Santelys are co-investing. The financing round is completed by non-dilutive financing, in the form of a grant and debt from BPIFrance and the EIC accelerator.
More information on presse release below:
SUCCESS OF THE FIRST BREAST RECONSTRUCTION SURGERY WITH MATTISSE
|SUCCESS OF THE FIRST BREAST RECONSTRUCTION SURGERY WITH MATTISSE 🚀|
On July 12, 2022, a first patient with breast cancer was able to undergo breast reconstruction with our #MATTISSE implant. The surgery took place at the Institute of Clinical Oncology in Tbilisi, Georgia.
It was conducted by Professor Gia Nemsadze and his team, and in the presence of the co-founders of Lattice Medical, Professor Pierre Guerreschi, Professor Philippe Marchetti, (both PUPH at the University Hospital of Lille) and Mr Julien Payen.
Two months after the operation, the healing is complete and the patient is in very good health.
More information in the press release below 👇
Lattice Medical Launches its Clinical Trials
|LATTICE MEDICAL LAUNCHES ITS CLINICAL TRIALS 🚀|
And here we are! After 3 years of work, we announce the start of our clinical trials and the inclusion of a first patient eligible for breast reconstruction with #MATTISSE for her breast cancer.
This is a world first 🏆for this type of technology, #madeinfrance totally resorbable, 3D printed, allowing a natural breast reconstruction, with a simple and unique surgery.
We hope to provide an alternative to current silicone implants and techniques used in #breastreconstruction. Thanks to the The Guardian newspaper for announcing this exclusive in their article on Sunday: https://lnkd.in/e4gH49TB
This is a real recognition of the quality work undertaken by the LATTICE MEDICAL team for over 3 years, recognised and published in three peer-reviewed journals. Thank you to all our partners and investors who have supported us since the beginning of the adventure to achieve this first!
More information in the press release.
NEWS
Lattice Medical lance sa collecte WiSEED en vue de financer ses essais cliniques !
🐱🏍3 ans après sa première levée de fonds, Lattice Medical relance une nouvelle collecte dans l’objectif principal de financer le premier essai clinique de l’implant MATTISSE afin de faire bénéficier d’une reconstruction mammaire naturelle, simple et sans risque aux femmes ayant eu une mastectomie dans leur traitement du cancer du sein.
👍Nous tenons à remercier l’équipe de gestion de WiSEED de refaire confiance à l’équipe Lattice Medical qui a franchi de grandes étapes lors de ces trois dernières années.
💖Et nous remercions d’ores et déjà toute la communauté des WiSEEDers qui font et referont confiance dans notre projet.
N’hésitez pas à poser vos questions, commenter et partager notre collecte, notre ambition reste la même : remplacer les implants silicones et aider 40 000 femmes d’ici 2030 à avoir une reconstruction mammaire plus simple et sans risques. 🙌
AVRIL 2021: LATTICE MEDICAL RECRUTE UN STAGE GRAPHISTE ET WEBDESIGN
Lattice Medical recrute un ou une étudiante de formation graphiste webdesigner en stage pour réaliser la création d’animations de chirurgie pour l’implant MATTISSE, de graphismes et illustrations et optimiser et mettre à jour notre site internet Lattice médical»
Contact : recrutement@lattice-medical.com
L’offre : Offre Stage Webdesigner
APRIL 2021: LATTICE MEDICAL IS RECRUITING ITS NEW REGULATORY AND QUALITY MANAGER
Do you want a new challenge ?
We Hiring !
“Quality and Regulatory affairs Manager”
In order to register our medical device initially in Europe, the USA and internationally, we need a leader who can manage all the regulatory elements, obtain and maintain the CE/FDA mark, establish the link with the regulatory authorities, notified body as well as the experienced Q / AR consultants.
Manage the regulatory/quality team, support the implementation of ISO 13485 certification and drive the clinical evaluation plan for our first-in-human in 2022.
So join us !
Contact : recrutement@lattice-medical.com
Quality Regulatory Affairs Manager – 2021 VA
PARTNERS
CONTACT